糖尿病性视网膜病变及分期与血瘀相关指标的分析研究
|
摘要
目的：通过分析2型糖尿病性视网膜病变(Diabetic retinopathy, DR)患者和健康成年人的血常规中红细胞和血小板各参数及其他相关因素,探讨红细胞和血小板各参数对于DR治疗的临床意义。
方法：选取2004年1月—2008年12月在成都中医药大学附属医院眼科已确诊为DR的住院病人106例,记录一般情况,由我院眼科医生进行眼底镜检查,FFA检查,检测患者入院后第一次血常规等。以82例健康成年人做对照组,应用spssl3.0统计软件,通过T检验、方差分析等统计方法,对比分析DR患者和健康成年人及DR不同分期(增殖期和非增殖期)的血常规中血小板各参数及红细胞各参数的变化,为DR及DR分期的治疗提供参考依据。
结果：1、红细胞各参数：DR组、NPDR组、PDR组分别与对照组比较,RBC(红细胞数目)、HGB(血红蛋白),HCT(红细胞比容),MCV(红细胞平均体积),MCHC(红细胞平均血红蛋白浓度),差异具有显著的统计学意义,P<0.01；DR组、PDR组分别与对照组相比,RDW-CV(红细胞分布宽度变异系数)有显著统计学意义,P<0.01。在NPDR组和PDR组比较中,MCHC、RDW-CV差异具有统计学意义,P<0.05。MCH(红细胞平均血红蛋白量),各组间比较,差异均不具有统计学意义,P>0.05。
2、血小板各参数：PLT(血小板计数),各组间比较均不具有统计学意义,P>0.05；MPV(血小板平均体积)、PCT(血小板压积)参数在DR组、PDR组分别与对照组比较中,差异具有统计学意义,P<0.05；PDW(血小板分布宽度)在DR组、NPDR组、PDR组分别与对照组比较中,差异具有显著统计学意义,P<0.01；在NPDR组和PDR组间比较中,血小板四参数均不具有统计学意义,P>0.05。
3、年龄：NPDR组和PDR组发病的年龄相比,差异具有统计学意义,P<0.05。
4、性别：发生DR、NPDR和PDR的性别比较,差异无统计学意义,P>0.05。
5、糖尿病病程与糖尿病视网膜病变严重程度的关系：具有统计学意义P<0.05。
结论：在本文条件下红细胞,各参数中RBC、HGB、HCT、MCV、MCHC、RDW-CV参数对于DR临床治疗有参考意义,其中MCHC、RDW-CV对于NPDR和PDR分期治疗有一定指导的意义；血小板各参数中MPV、PDW、PCT与DR有相关性,对于DR的治疗有指导意义。血小板四参数(PLT, MPV, PCT, PDW)对于DR不同分期的治疗均不具有临床指导性。DR、NPDR和PDR发病与性别无关。DR发生的年龄越小,发生PDR的几率越大。DR的严重程度与DM病程呈正相关。
Objective:To explore the clinical treatment significance of various parameters of red blood cell, platelet and other relevant factors in DR, through analysising them in patients with Diabetic retinopathy and healthy adults.
Methods:We selected 106 patients who have been diagnosed as DR from January 2004 to December 2008 in Chengdu University of Traditional Chinese Medicine Affiliated Hospital. The oculist have made record of their general conditions and all the patients had ophthalmoscope examination, FFA examination and blood routine test during their first visit.82 healthy adults was in the control group.We used statistical software spss13.0 and T-test,ANOVA statistical methods to analysis the changes in the various parameters of red blood cell and platelet between DR and healthy adults, NPDR and PDR.We were expected to provide referenced treatment evidence on DR and in different phases of DR.
Results:1、Parameters of Red blood cell:Compare control group with DR group,NPDR group and PDR group, there was significant statistically difference in RBC(red blood cell count), HGB(hemoglobin),HCT (hematocrit), MCV (mean corpuscular volume), MCHC (mean corpuscular hemoglobin concentration). P＜0.01; Compare control group with DR group and NPDR group there was significant statistically difference in RDW-CV(red blood cell volume distribution width).P<0.01;compare NPDR group with PDR group there was statistically difference in RDW-CV and MCHC, P＜0.05. However, there was no statistically difference among all groups in MCH. (mean corpuscular hemoglobin volume)P> 0.05.
2、Parameters of Platelet:There was no statistically difference among all groups in PLT (platelet count).P> 0.05; Compare control group with DR group and NPDR group there was statistically difference in MPV (mean platelet volume) and PCT (Pressure platelet plot). P<0.05; Compare control group with DR group,NPDR group and PDR group, there was significant statistically difference in PDW (platelet distribution width).P<0.01; Compaire NPDR group with PDR group there was no statistically difference in the 4 parameters of platelet.
3、Age:Compaire NPDR group with PDR group there was statistical significance in age.P<0.05.
4、Gender:the comparison in terms of gender of DR patients, including NPDR and PDR patients has no statistical significance, P> 0.05.
5.The relationship between diabetes duration and severity of diabetic retinopathy:the difference has statistical significance, P＜0.05.
Conclusion:Among Red blood cell parameters, theRBC, HGB, HCT, MCV, MCHC and RDW-CV parameters have clinically reference significance for the treatment of DR, and the MCHC, RDW-CV has certain clinical significance for the treatment of NDPR and DPR. Among platelet parameters, the chang of the RDW, MPV, and PCT have correlative with DR, they have clinically reference significance for the treatment of DR. The four platelet parameters have not statistically significant in comparison of NPDR group and PDR group. The occurrence of DR including the occurrence of NPDR and PDR is unrelated to gender. The younger age DR occurs in, the more probable PDR would occur. The occurrence of NPDR and PDR was positively related to the length of the courses of DM.
方法：选取2004年1月—2008年12月在成都中医药大学附属医院眼科已确诊为DR的住院病人106例,记录一般情况,由我院眼科医生进行眼底镜检查,FFA检查,检测患者入院后第一次血常规等。以82例健康成年人做对照组,应用spssl3.0统计软件,通过T检验、方差分析等统计方法,对比分析DR患者和健康成年人及DR不同分期(增殖期和非增殖期)的血常规中血小板各参数及红细胞各参数的变化,为DR及DR分期的治疗提供参考依据。
结果：1、红细胞各参数：DR组、NPDR组、PDR组分别与对照组比较,RBC(红细胞数目)、HGB(血红蛋白),HCT(红细胞比容),MCV(红细胞平均体积),MCHC(红细胞平均血红蛋白浓度),差异具有显著的统计学意义,P<0.01；DR组、PDR组分别与对照组相比,RDW-CV(红细胞分布宽度变异系数)有显著统计学意义,P<0.01。在NPDR组和PDR组比较中,MCHC、RDW-CV差异具有统计学意义,P<0.05。MCH(红细胞平均血红蛋白量),各组间比较,差异均不具有统计学意义,P>0.05。
2、血小板各参数：PLT(血小板计数),各组间比较均不具有统计学意义,P>0.05；MPV(血小板平均体积)、PCT(血小板压积)参数在DR组、PDR组分别与对照组比较中,差异具有统计学意义,P<0.05；PDW(血小板分布宽度)在DR组、NPDR组、PDR组分别与对照组比较中,差异具有显著统计学意义,P<0.01；在NPDR组和PDR组间比较中,血小板四参数均不具有统计学意义,P>0.05。
3、年龄：NPDR组和PDR组发病的年龄相比,差异具有统计学意义,P<0.05。
4、性别：发生DR、NPDR和PDR的性别比较,差异无统计学意义,P>0.05。
5、糖尿病病程与糖尿病视网膜病变严重程度的关系：具有统计学意义P<0.05。
结论：在本文条件下红细胞,各参数中RBC、HGB、HCT、MCV、MCHC、RDW-CV参数对于DR临床治疗有参考意义,其中MCHC、RDW-CV对于NPDR和PDR分期治疗有一定指导的意义；血小板各参数中MPV、PDW、PCT与DR有相关性,对于DR的治疗有指导意义。血小板四参数(PLT, MPV, PCT, PDW)对于DR不同分期的治疗均不具有临床指导性。DR、NPDR和PDR发病与性别无关。DR发生的年龄越小,发生PDR的几率越大。DR的严重程度与DM病程呈正相关。
Objective:To explore the clinical treatment significance of various parameters of red blood cell, platelet and other relevant factors in DR, through analysising them in patients with Diabetic retinopathy and healthy adults.
Methods:We selected 106 patients who have been diagnosed as DR from January 2004 to December 2008 in Chengdu University of Traditional Chinese Medicine Affiliated Hospital. The oculist have made record of their general conditions and all the patients had ophthalmoscope examination, FFA examination and blood routine test during their first visit.82 healthy adults was in the control group.We used statistical software spss13.0 and T-test,ANOVA statistical methods to analysis the changes in the various parameters of red blood cell and platelet between DR and healthy adults, NPDR and PDR.We were expected to provide referenced treatment evidence on DR and in different phases of DR.
Results:1、Parameters of Red blood cell:Compare control group with DR group,NPDR group and PDR group, there was significant statistically difference in RBC(red blood cell count), HGB(hemoglobin),HCT (hematocrit), MCV (mean corpuscular volume), MCHC (mean corpuscular hemoglobin concentration). P＜0.01; Compare control group with DR group and NPDR group there was significant statistically difference in RDW-CV(red blood cell volume distribution width).P<0.01;compare NPDR group with PDR group there was statistically difference in RDW-CV and MCHC, P＜0.05. However, there was no statistically difference among all groups in MCH. (mean corpuscular hemoglobin volume)P> 0.05.
2、Parameters of Platelet:There was no statistically difference among all groups in PLT (platelet count).P> 0.05; Compare control group with DR group and NPDR group there was statistically difference in MPV (mean platelet volume) and PCT (Pressure platelet plot). P<0.05; Compare control group with DR group,NPDR group and PDR group, there was significant statistically difference in PDW (platelet distribution width).P<0.01; Compaire NPDR group with PDR group there was no statistically difference in the 4 parameters of platelet.
3、Age:Compaire NPDR group with PDR group there was statistical significance in age.P<0.05.
4、Gender:the comparison in terms of gender of DR patients, including NPDR and PDR patients has no statistical significance, P> 0.05.
5.The relationship between diabetes duration and severity of diabetic retinopathy:the difference has statistical significance, P＜0.05.
Conclusion:Among Red blood cell parameters, theRBC, HGB, HCT, MCV, MCHC and RDW-CV parameters have clinically reference significance for the treatment of DR, and the MCHC, RDW-CV has certain clinical significance for the treatment of NDPR and DPR. Among platelet parameters, the chang of the RDW, MPV, and PCT have correlative with DR, they have clinically reference significance for the treatment of DR. The four platelet parameters have not statistically significant in comparison of NPDR group and PDR group. The occurrence of DR including the occurrence of NPDR and PDR is unrelated to gender. The younger age DR occurs in, the more probable PDR would occur. The occurrence of NPDR and PDR was positively related to the length of the courses of DM.
引文
[1].King H, Rewers M, etal, Diabetes in adults is now a third world Problem. [J]Wbrld Health organizationon Ad Hoc Diabetes RePorting GrouP. Etlln Dis,1993,3 (Suppl):S67—74.
[2].Dabelea D, Pettitl DJ, Jones KL, et al.Type 2 Diabetes mellitus in minority children and adolescents[J]. An emering Problem. Endocrinol Metab Clin North Am,1999,28(4):709—729.
[3].钱荣立.严格控制糖尿病减少糖尿病合并症[J].中华内科杂志,1994,33(3)：147.
[4].张承芬,申尊茂.眼科新编[M].北京：人民卫生出版社,1991.41—418.
[5].Xiang HD. The morbility of chronic complication of Chinese patiens with 1991—2000[J]. Diabetes Research and Clinical Practice,2000,56 56 (suppl):84.
[6].Nakjima M, Cooney MJ,Alexander HT, et al. Normalization of retinal vascular permeability in experimental diabetes with genistein [J] Invest Ophthalmol Vis Sci,2001,42(9):2110—2114.
[7].叶山东,李素梅,戴海明,等.糖尿病合并蛋白尿患者血小板聚集功能和膜糖蛋白表达的变化[J].中国糖尿病杂志,2001,9(4)：207-209.
[8].曾祥义,张书模,张荷.非胰岛素依赖型糖尿病患者循环内皮细胞的变化及临床意义[J].临床内科杂志,1996,13(5)：34.
[9].朱慧琴.112例糖尿病患者血液流变学结果分析[J].中华检验医学杂志,2002,25(3)：180.
[10].张润香,胡春松,陈五一.Ⅱ型糖尿病患者红细胞和血小板聚集变化及络泰对其的影响[J].江西医学院学报,2005,45(2)：64-65.
[11].毛达勇,周有利,李德奎.糖尿病并血管病变患者血小板膜糖蛋白CD62p,CD63的表达及血小板四参数的研究[J].中国循环杂志.2003,18(5)：367-368.
[12].董立均,邵晓颖.中西医结合治疗糖尿病视网膜病变48例分析[J].吉林中
医药,2000,20(6):52.
[13].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[14].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[15].梁光宇.冯明清教授治疗糖尿病学术思想简介[J].河南中医,2000,20(1)：15.
[16].谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2)：86-88.
[17].沈志祥,王鸿利,支立民,等.糖尿病患者高凝状态的临观察[J].中华内分泌代谢杂志,1990,(4)：206.
[18].第二届全国活血化瘀研究学术会议.血瘀证诊断标准[J].中国中西医结合杂志,1987,37：129.
[19]. Berinstein DM, Stahn RM, Welty TK, et al.The prevalence of diabetic retinopathy and associated risk factors among Siou India[J]. Diabetes care,1997,20:757-759.
:[20].Haddad OA, Saad MK. Prevalence and risk factors for diabetic reti-nopathy among Omani diabetics[M]. Br. J. Ophthalmol,1998,82:901-906.
[21].徐琪,彭亚军,陆健,等.Ⅱ型糖尿病患者并发视网膜病变的临床分析(附304例报告)[J].第二军医大学学报,1999,20(7)：477-479.
[22].EI-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. Risk factors for diabetic retinopathy among Saudi diabetics[J]. International Ophthalmology,1999,22:155-161.
[23]. Tung TH, Chen SJ, Liu JH, et al.A community-based follow up study on diabetic retinopathy among type 2 diabetics in Kimen[J]. European Journal of pidemiology,2005,20:317-323.
[24].吴红光,杨文东,韩景银,等.2型糖尿病患者发病年龄与微血管病变的临床研究[J].实用医技杂志,2006,13(11)：1924—1925.
[25]. Ng MC, Lee SC, Ko GT, et al. Familial early-onset type 2 diabetes in Chinese patients[J]. Diabetes Care,2001,24:663-671.
[26]. Aguilar-Salinas CA, Reyes-Rodr i guez E, Ordonez-Sanchez ML, et al. Early-onset type 2 diabetes:metabolic and genetic character-Ization in the mexican population [J]. J Clin Endocrinol Metab, 2001,86:220-226.
[27]. Kim TY, Song JY, Kin WB, et al. High incidence of diabetic nephropathy in early onest Japanese NIDDM patients [J]. Diabetes Care,1998,21: 1080-1085.
[28].张敏,李红,张哲.早发2型糖尿病临床特征及慢性并发症相关因素的分析[J].中华医学杂志.2006,86(36)：2547-2551.
[29].吴红光,杨文东,韩景银,等.2型糖尿病患者发病年龄与微血管病变的临床研究[J].实用医技杂志,2006,13(11)：1924—1925.
[30].韩学尧,纪立农.家族性早发2型糖尿病的病理生理和临床特征[J].中华糖尿病杂志,2005,13(2)：51-52.
[31].陈雨,朱晓华.糖尿病视网膜病变发病机制的研究进展[J].国际眼科杂志,2006(2)：45-47.
[32]. Falkenberg M, Finnstrom K. Associations with retinopathy in type-2 diabetes:a population-based study in a Swedish rural area[J]. Diab-etic Med,1994,11:843.
[33].Moss SE, Klein R, Klein BEK. Ten year incidence of visual loss in a diabetic popuLation[J]. Ophthalmolgy,1994,101:1061.
[34].Priem HA. Diabetes mellitus and the eye[J].Acta Clin Belg,2004,59 (5):237-240.
[35].何志明,梁瑜祯.2型糖尿病视网膜病变危险因素相关分析[J].中国慢性病预防与控制,2004,12(6)：272-273.
[36]. Winocour PD. Platelet abnormalities in diabetes Mellitus [J]. Diabe-tes,1992,42:332.
[37].严孙杰,卓孝福,胡雯,等.糖尿病患者红细胞Na--K+ATPase、Ca2+-ATPase 活性变化[J].福建医学院学报,1996,30：257.
[38].严孙杰,卓孝福,吴长珠,等.糖尿病患者自由基与红细胞膜Na+-K+-ATPase、Ca2+-ATPase损伤的关系[J].中华内分泌代谢杂志,1997,12：124.
[39].兰帆,张素华,邱鸿鑫,等.Ⅱ型糖尿病患者钠-钾逆转换活性改变[J].中华糖尿病杂志,2008,8：131.
[40].严孙杰,卓孝福,潘时中,等.糖尿病患者血细胞体积增大在微血管病变中的作用[J].中国糖尿病杂志,2000.8(2)：89-91.
[41].李延延,程时,潘子昂,等.Ⅱ型糖尿病患者和糖尿病鼠的红细胞形态观察[J].中华医学杂志,1992,72：103.
[42].杨刚.内分泌生理与病理生理学[M].天津.天津科学技术出版社,1996,456-458.
[43].王融,吴学涛,彭慧敏,等.2型糖尿病红细胞体积分布宽度的床分析[J].血栓与止血学,2004,10(3)：131-132.
[44].王融,崔其亮.红细胞体积分布宽度值对新生儿黄疸病诊断价值探讨[J].青海医药杂志,2002,32(12)：1-3.
[45].张晓鸣,杜国有.血小板参数在2型糖尿病及其并发症中的检测分析[J].右江民族医学院学报,2004,6：827-828.
[46].李英兰,滕长青.2型糖尿病患者血尿酸及血小板四项参数检测的临床意义[J].青海医药杂志,2001,31(8)：10-11.
[47].李淑翠,李淑芬.血小板参数及糖化血红蛋白测定在糖尿病微血管病变中的意义[J].中国误诊学杂志,2004,4(5)：725-726.
[48].金长碧.2型糖尿病病人的血小板4项参数检测的临床意义[J].临床和实验医学杂志.2006,5(2)：160-161.
[49]. Craig BT, Katherine A. Size dependent platelet subpopulations relationship of platelet volume to ultra structure enzymatic activity and function[J]. Br J Hematology,1982,50:509-510.
[50].董立均,邵晓颖.中西医结合治疗糖尿病视网膜病变48例分析[J].吉林中医药,2000,20(6)：52.
[51].梁光宇,冯明清教授治疗糖尿病学术思想简介[J].河南中医,2000,20(1)： 15.
[52].谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2)：86-88.
[53].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[54].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[55].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[56].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[57].高健,顾振纶,王天佑.血淤症与血液流变学的关系及其中药研究进展[J].中国血液流变学杂志,2003,2(13)：183-185.
[58].高听媛,匡洪宇,邹伟,等.糖网明对糖尿病大鼠视网膜神经细胞保护作用的实验研究[J].中国中医药科技,2005,12(4)：214-215.
[59].秦大军.活血化淤中药的眼科使用指针[J].实用眼科杂志,1988,6(10)：637-638.
[60].柯晓云.丹参对糖尿病视网膜病变患者脂质过氧化物歧化酶的影响[J].中国中医眼科杂志,1997,(4)：206.
[61].唐刚华,姜国辉,唐小兰.川芎哚及其类似物对凝血功能和血液流变学的影响[J].2002,18(2)：238-239.
[62].梁晓声,郭赛珊.肾虚衰老与自由基的关系以及补肾对自由基的影响[J].中西医结合杂志,1991,(7)：427.
[63].王艳伟,林娜,乔利.中药对红细胞膜结构和功能影响的研究进展[J].中国实验方剂学杂志.2006,12(11)：64-67.
[64].史秀丽,傅佳,李光武.血小板靶向中药有效成分及单体研究进展[J].中国中药杂志.2006,3(5)：361-364.
[65].任少兰.活血化瘀法治疗糖尿病性视网膜病变的疗效观察[J].辽宁中医杂志2003,30(6)：478.
[66].周文军.灯盏花素伍用降纤酶治疗脑梗死38例分析[J],实用神经疾病杂志,2005,8(3)：79-80.
[67].陈开地.高粘血症患者血液流变学研究[J].中国微循环,1998,2(2)：108.
[68].林梅.从虚从瘀论治糖尿病[J].四川中医,2005,23(3)63-65.
[1].张承芬,申尊茂.眼科新编[M].北京：人民卫生出版社,1991.41-418.
[2].Nakjima M, Cooney MJ, Alexander HT,et al.Normalization of retinal vascular permeability in experimental diabetes with genistein[J]. Invest Ophthalmol Vis Sci,2001,42(9):2110-2114.
[3].Xiang HD. The morbility of chronic complication of Chinese patiens with 1991-2000[J]. Diabetes Research and Clinical Practice,2000, 56(suppl):84.
[4].张慧蓉,眼微循环及其相关疾病[M],北京：北京医科大学,协和医科大学联合出版社,1993：160.
[5].Kuroki M, Kawakami M. Diabetic retinopathy the mechinisms of the ocular nevascularization and development of anti-angiogemic drugs[J]. Nippon Rinsho,1999:57:584-589.
[6].黄敬泽,张珍,王健.外周血循环内皮细胞,血浆内皮素与糖尿病视网膜病变的关系[J].中华眼底病杂志,2000,16(3)：1661-1681.
[7].胡蜀红,张建华,蔡仕林.糖尿病视网膜病变与血浆内皮素的关系[J].临床荟萃,2003,18(12)：677-678.
[8].张雪莲,杨金奎.糖尿病视网膜病变的若干生物化学和分子生物学机制[J].微循环学,2004,14(12)：56-58.
[9].陈雨,朱晓华.糖尿病视网膜病变发病机制的研究进展[J].国际眼科杂志,2006,6(2)：45-47.
[10].郁知非.现代血液病学.贫血及红细胞系疾病分册[M].浙江：浙江科学技术出版社,1989：7—8.
[11]. Sonkin PL, Chen LE, Seaber AV, et al. Vasodilatoraction of pentoxify-Lline on microcirculation of rat crimaster muscle. Angiology,1992, 43:462.
[12].曾祥义,张书模,张荷.非胰岛素依赖型糖尿病患者循环内皮细胞的变化及临床意义[J].临床内科杂志,1996,13(5)：34.
[13].朱慧琴.112例糖尿病患者血液流变学结果分析[J].中华检验医学杂志, 2002,25(3)：180.
[14].何作云,冯兵,尹翠娥,等.红细胞聚集调控血压机理实验研究[J].中华心血管病杂志,1997,25(2)：115.
[15].张润香,胡春松,陈五一.Ⅱ型糖尿病患者红细胞和血小板聚集变化及络泰对其的影响[J].江西医学院学报,2005,45(2)：64-65.
[16]. Winocour PD. Platelet abnormalities in diabetes Mellitus[J]. Diabetes,1992,42:445.
[17].严孙杰,卓孝福,胡雯,等.糖尿病患者红细胞Na+-K+ATPase, Ca2+-ATPase活性变化[J].福建医学院学报,1996,30：257.
[18].严孙杰,卓孝福,吴长珠,等.糖尿病患者自由基与红细胞膜Na+-K+-ATPase、 Ca2+-ATPase损伤的关系[J].中华内分泌代谢杂志.1997,12：124.
[19].兰帆,张素华,邱鸿鑫,等.Ⅱ型糖尿病患者钠-钾逆转换活性改变[J].中华糖尿病杂志,2008,8：133-134.
[20].李延延,程时,潘子昂,等.Ⅱ型糖尿病患者和糖尿病鼠的红细胞形态观察[J].中华医学杂志,1992,(2)：103.
[21].严孙杰,卓孝福,潘时中,等.糖尿病患者血细胞体积增大在微血管病变中的作用[J].中国糖尿病杂志,2000,8(2)：89-91.
[22].阮长耿.血小板的形态学[M].上海：上海科学技术出版社,1987：232-235.
[23].从玉隆,王淑娟.今日临床检验学[M].北京：中国科学技术出版社,1997,4-10.
[24].王融,吴学涛,彭慧敏,等.2型糖尿病红细胞体积分布宽度的床分析[J].血栓与止血学,2004,10(3)：131-132.
[25]. Mariella Trovati, Elena M, Serenella Burzacca, et al. Impaired insulin-induced platelet antiaggregating effect in obesity and obese NIDDM patients [J]. Diabetes,1995,44(11):1318.
[26].RogerD, Nolan, Arron Ⅳ.Pathogenesis of Platlet dysfunction in diabetes. In:Derek LR.Simeon LT and Jerrold moeds. Diabetes Mellitus[M]. Philadelphia:Lippincon-Raven Publishers,1996: 832-839.
[27]. Colwell JA.Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus[J]. Metabolism,1994,41(suppl 1): 7.
[28].毛达勇,周有利,李德奎.糖尿病并血管病变患者血小板膜糖蛋白CD62p,CD63的表达及血小板四参数的研究[J].中国循环杂志.2003,18(5)：367-368.
[29].张晓鸣,杜国有.血小板参数在2型糖尿病及其并发症中的检测分析[J].右江民族医学院学报,2004,6：827-828.
[30].金长碧.2型糖尿病病人的血小板4项参数检测的临床意义[J].临床和实验医学杂志,2006,5(2)：160-161.
[31].李英兰,滕长青.2型糖尿病患者血尿酸及血小板四项参数检测的临床意义[J].青海医药杂志,2001,31(8)：10-11.
[32].李淑翠,李淑芬.血小板参数及糖化血红蛋白测定在糖尿病微血管病变中的意义[J].中国误诊学杂志2004,4(5)：725-726.
[33].贾安奎,糖尿病视网膜病变患者血小板平均体积及血小板聚集功能的测定[J].中国误诊学杂志,2006,6(18),35-38.
[34].Carr ME. Diabetes mellitus:a hypercoagulable state[J]. Diabete Complications,2001,15(1):44.
[35]. Saga T, Aoyama T, Takekoshi T. Changes in the number and volume of platelets in male elderly persons, and effects of various factors on them[J]. Nippon Ronen Igakkai Zasshi,1995,32(4):270-276.
[36].Craig BT, Katherine AE.Size dependent platelet subpopulations relationship of platelet volume to ultrastructure enzymatic activity and function[J]. Br J Haematology,1982,50:509.
[37].薛耀明,徐爱华.胰岛素依赖型糖尿病及其并发症患者血小板超微结构的形态计量学研究[J].中华内分泌代谢杂志,1995,11：16.
[38].吴伽,蔡爱玲.糖尿病合并微血管病变患者血细胞体积改变及其临床意义[J].微循环学杂志,2004,14(3)：91.
[39].金秀国,方国安,刘波,等.2型糖尿病患者血小板参数和CD62p表达率 的变化及相关关系[J].浙江临床医学,2002,4(11)：803-804.
[40].黄东生,吕善根.血小板平均容积在某些疾病中的变化及其临床意义[J].国外医学·输血及血液血分册,1995,18(6)：331-333.
[41].黄瑞勇,糖尿病人血小板各项参数变化的临床意义(附113例分析)[J]：右江医学2001,29(1)：332.
[42].董立均,邵晓颖.中西医结合治疗糖尿病视网膜病变48例分析[J].吉林中医药,2000,20(6)：52.
[43].梁光宇.冯明清教授治疗糖尿病学术思想简介[J].河南中医,2000,20(1)：15.
[44].谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2)：86-88.
[45].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[46].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[47]. Tuomilehto J, Del Prato S. Mealtime glucose regulation in typ-2 diabetes[J]. Int J Clin Pract,2001,55(6):380-383.
[48]The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the dvelopment and progression of long-term complications in insulin dependent diabetes mellitus [J]. New Engl J Med,1993,32(14):977-986.
[49]. UK Prospective Diabetes (UKPDS) Group. Intensive blood glucose control with conventional treatment and risk of complictions in patients with Type 2 diabetes (UKPDS 33)[J]. Lancet,1998,352: 837-853.
[50]. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive diabetes treatment on the progression of retinopathy in insulin-dependent diabetes mellitu[J]. Arch Ophth-almol,1995,113:36-51.
[51].Kehner EM, Aldington SJ, Stratton IM, et al. United Kingdom prospective diabetes study. Dabetic retinopathy at diagnose of non-insulin-dependent diabetes mellitus and associated risk fators[J]. Arch Ophthalmol,1998,116(3):297-303.
[52].Neely KA, Quillen DA, Schachat AP, et al. Diabetic retinopathy [J]. Med Clin North Am,1998,82(4):847-876.
[53]Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. ETDRS Report 22 [J]. Arch Ophthalmol,1996,114:1079-1084.
[54].Adiel Barak MD, Michael Regenbogen MD, Michaella Goldstein MD and Anat Loewenstein MD.Intravitreal Triamci nolone Injection for Diff-use Diabetic Macular Edema with Foveal Cystoid Changes[J]. IMAJ, 2006; 8(2):83-87.
[55].陈瑾,徐国兴.糖尿病视网膜病变相关研究进展[J].海峡科学,2007.(3)：21-23.
[2].Dabelea D, Pettitl DJ, Jones KL, et al.Type 2 Diabetes mellitus in minority children and adolescents[J]. An emering Problem. Endocrinol Metab Clin North Am,1999,28(4):709—729.
[3].钱荣立.严格控制糖尿病减少糖尿病合并症[J].中华内科杂志,1994,33(3)：147.
[4].张承芬,申尊茂.眼科新编[M].北京：人民卫生出版社,1991.41—418.
[5].Xiang HD. The morbility of chronic complication of Chinese patiens with 1991—2000[J]. Diabetes Research and Clinical Practice,2000,56 56 (suppl):84.
[6].Nakjima M, Cooney MJ,Alexander HT, et al. Normalization of retinal vascular permeability in experimental diabetes with genistein [J] Invest Ophthalmol Vis Sci,2001,42(9):2110—2114.
[7].叶山东,李素梅,戴海明,等.糖尿病合并蛋白尿患者血小板聚集功能和膜糖蛋白表达的变化[J].中国糖尿病杂志,2001,9(4)：207-209.
[8].曾祥义,张书模,张荷.非胰岛素依赖型糖尿病患者循环内皮细胞的变化及临床意义[J].临床内科杂志,1996,13(5)：34.
[9].朱慧琴.112例糖尿病患者血液流变学结果分析[J].中华检验医学杂志,2002,25(3)：180.
[10].张润香,胡春松,陈五一.Ⅱ型糖尿病患者红细胞和血小板聚集变化及络泰对其的影响[J].江西医学院学报,2005,45(2)：64-65.
[11].毛达勇,周有利,李德奎.糖尿病并血管病变患者血小板膜糖蛋白CD62p,CD63的表达及血小板四参数的研究[J].中国循环杂志.2003,18(5)：367-368.
[12].董立均,邵晓颖.中西医结合治疗糖尿病视网膜病变48例分析[J].吉林中
医药,2000,20(6):52.
[13].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[14].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[15].梁光宇.冯明清教授治疗糖尿病学术思想简介[J].河南中医,2000,20(1)：15.
[16].谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2)：86-88.
[17].沈志祥,王鸿利,支立民,等.糖尿病患者高凝状态的临观察[J].中华内分泌代谢杂志,1990,(4)：206.
[18].第二届全国活血化瘀研究学术会议.血瘀证诊断标准[J].中国中西医结合杂志,1987,37：129.
[19]. Berinstein DM, Stahn RM, Welty TK, et al.The prevalence of diabetic retinopathy and associated risk factors among Siou India[J]. Diabetes care,1997,20:757-759.
:[20].Haddad OA, Saad MK. Prevalence and risk factors for diabetic reti-nopathy among Omani diabetics[M]. Br. J. Ophthalmol,1998,82:901-906.
[21].徐琪,彭亚军,陆健,等.Ⅱ型糖尿病患者并发视网膜病变的临床分析(附304例报告)[J].第二军医大学学报,1999,20(7)：477-479.
[22].EI-Asrar AM, Al-Rubeaan KA, Al-Amro SA, et al. Risk factors for diabetic retinopathy among Saudi diabetics[J]. International Ophthalmology,1999,22:155-161.
[23]. Tung TH, Chen SJ, Liu JH, et al.A community-based follow up study on diabetic retinopathy among type 2 diabetics in Kimen[J]. European Journal of pidemiology,2005,20:317-323.
[24].吴红光,杨文东,韩景银,等.2型糖尿病患者发病年龄与微血管病变的临床研究[J].实用医技杂志,2006,13(11)：1924—1925.
[25]. Ng MC, Lee SC, Ko GT, et al. Familial early-onset type 2 diabetes in Chinese patients[J]. Diabetes Care,2001,24:663-671.
[26]. Aguilar-Salinas CA, Reyes-Rodr i guez E, Ordonez-Sanchez ML, et al. Early-onset type 2 diabetes:metabolic and genetic character-Ization in the mexican population [J]. J Clin Endocrinol Metab, 2001,86:220-226.
[27]. Kim TY, Song JY, Kin WB, et al. High incidence of diabetic nephropathy in early onest Japanese NIDDM patients [J]. Diabetes Care,1998,21: 1080-1085.
[28].张敏,李红,张哲.早发2型糖尿病临床特征及慢性并发症相关因素的分析[J].中华医学杂志.2006,86(36)：2547-2551.
[29].吴红光,杨文东,韩景银,等.2型糖尿病患者发病年龄与微血管病变的临床研究[J].实用医技杂志,2006,13(11)：1924—1925.
[30].韩学尧,纪立农.家族性早发2型糖尿病的病理生理和临床特征[J].中华糖尿病杂志,2005,13(2)：51-52.
[31].陈雨,朱晓华.糖尿病视网膜病变发病机制的研究进展[J].国际眼科杂志,2006(2)：45-47.
[32]. Falkenberg M, Finnstrom K. Associations with retinopathy in type-2 diabetes:a population-based study in a Swedish rural area[J]. Diab-etic Med,1994,11:843.
[33].Moss SE, Klein R, Klein BEK. Ten year incidence of visual loss in a diabetic popuLation[J]. Ophthalmolgy,1994,101:1061.
[34].Priem HA. Diabetes mellitus and the eye[J].Acta Clin Belg,2004,59 (5):237-240.
[35].何志明,梁瑜祯.2型糖尿病视网膜病变危险因素相关分析[J].中国慢性病预防与控制,2004,12(6)：272-273.
[36]. Winocour PD. Platelet abnormalities in diabetes Mellitus [J]. Diabe-tes,1992,42:332.
[37].严孙杰,卓孝福,胡雯,等.糖尿病患者红细胞Na--K+ATPase、Ca2+-ATPase 活性变化[J].福建医学院学报,1996,30：257.
[38].严孙杰,卓孝福,吴长珠,等.糖尿病患者自由基与红细胞膜Na+-K+-ATPase、Ca2+-ATPase损伤的关系[J].中华内分泌代谢杂志,1997,12：124.
[39].兰帆,张素华,邱鸿鑫,等.Ⅱ型糖尿病患者钠-钾逆转换活性改变[J].中华糖尿病杂志,2008,8：131.
[40].严孙杰,卓孝福,潘时中,等.糖尿病患者血细胞体积增大在微血管病变中的作用[J].中国糖尿病杂志,2000.8(2)：89-91.
[41].李延延,程时,潘子昂,等.Ⅱ型糖尿病患者和糖尿病鼠的红细胞形态观察[J].中华医学杂志,1992,72：103.
[42].杨刚.内分泌生理与病理生理学[M].天津.天津科学技术出版社,1996,456-458.
[43].王融,吴学涛,彭慧敏,等.2型糖尿病红细胞体积分布宽度的床分析[J].血栓与止血学,2004,10(3)：131-132.
[44].王融,崔其亮.红细胞体积分布宽度值对新生儿黄疸病诊断价值探讨[J].青海医药杂志,2002,32(12)：1-3.
[45].张晓鸣,杜国有.血小板参数在2型糖尿病及其并发症中的检测分析[J].右江民族医学院学报,2004,6：827-828.
[46].李英兰,滕长青.2型糖尿病患者血尿酸及血小板四项参数检测的临床意义[J].青海医药杂志,2001,31(8)：10-11.
[47].李淑翠,李淑芬.血小板参数及糖化血红蛋白测定在糖尿病微血管病变中的意义[J].中国误诊学杂志,2004,4(5)：725-726.
[48].金长碧.2型糖尿病病人的血小板4项参数检测的临床意义[J].临床和实验医学杂志.2006,5(2)：160-161.
[49]. Craig BT, Katherine A. Size dependent platelet subpopulations relationship of platelet volume to ultra structure enzymatic activity and function[J]. Br J Hematology,1982,50:509-510.
[50].董立均,邵晓颖.中西医结合治疗糖尿病视网膜病变48例分析[J].吉林中医药,2000,20(6)：52.
[51].梁光宇,冯明清教授治疗糖尿病学术思想简介[J].河南中医,2000,20(1)： 15.
[52].谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2)：86-88.
[53].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[54].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[55].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[56].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[57].高健,顾振纶,王天佑.血淤症与血液流变学的关系及其中药研究进展[J].中国血液流变学杂志,2003,2(13)：183-185.
[58].高听媛,匡洪宇,邹伟,等.糖网明对糖尿病大鼠视网膜神经细胞保护作用的实验研究[J].中国中医药科技,2005,12(4)：214-215.
[59].秦大军.活血化淤中药的眼科使用指针[J].实用眼科杂志,1988,6(10)：637-638.
[60].柯晓云.丹参对糖尿病视网膜病变患者脂质过氧化物歧化酶的影响[J].中国中医眼科杂志,1997,(4)：206.
[61].唐刚华,姜国辉,唐小兰.川芎哚及其类似物对凝血功能和血液流变学的影响[J].2002,18(2)：238-239.
[62].梁晓声,郭赛珊.肾虚衰老与自由基的关系以及补肾对自由基的影响[J].中西医结合杂志,1991,(7)：427.
[63].王艳伟,林娜,乔利.中药对红细胞膜结构和功能影响的研究进展[J].中国实验方剂学杂志.2006,12(11)：64-67.
[64].史秀丽,傅佳,李光武.血小板靶向中药有效成分及单体研究进展[J].中国中药杂志.2006,3(5)：361-364.
[65].任少兰.活血化瘀法治疗糖尿病性视网膜病变的疗效观察[J].辽宁中医杂志2003,30(6)：478.
[66].周文军.灯盏花素伍用降纤酶治疗脑梗死38例分析[J],实用神经疾病杂志,2005,8(3)：79-80.
[67].陈开地.高粘血症患者血液流变学研究[J].中国微循环,1998,2(2)：108.
[68].林梅.从虚从瘀论治糖尿病[J].四川中医,2005,23(3)63-65.
[1].张承芬,申尊茂.眼科新编[M].北京：人民卫生出版社,1991.41-418.
[2].Nakjima M, Cooney MJ, Alexander HT,et al.Normalization of retinal vascular permeability in experimental diabetes with genistein[J]. Invest Ophthalmol Vis Sci,2001,42(9):2110-2114.
[3].Xiang HD. The morbility of chronic complication of Chinese patiens with 1991-2000[J]. Diabetes Research and Clinical Practice,2000, 56(suppl):84.
[4].张慧蓉,眼微循环及其相关疾病[M],北京：北京医科大学,协和医科大学联合出版社,1993：160.
[5].Kuroki M, Kawakami M. Diabetic retinopathy the mechinisms of the ocular nevascularization and development of anti-angiogemic drugs[J]. Nippon Rinsho,1999:57:584-589.
[6].黄敬泽,张珍,王健.外周血循环内皮细胞,血浆内皮素与糖尿病视网膜病变的关系[J].中华眼底病杂志,2000,16(3)：1661-1681.
[7].胡蜀红,张建华,蔡仕林.糖尿病视网膜病变与血浆内皮素的关系[J].临床荟萃,2003,18(12)：677-678.
[8].张雪莲,杨金奎.糖尿病视网膜病变的若干生物化学和分子生物学机制[J].微循环学,2004,14(12)：56-58.
[9].陈雨,朱晓华.糖尿病视网膜病变发病机制的研究进展[J].国际眼科杂志,2006,6(2)：45-47.
[10].郁知非.现代血液病学.贫血及红细胞系疾病分册[M].浙江：浙江科学技术出版社,1989：7—8.
[11]. Sonkin PL, Chen LE, Seaber AV, et al. Vasodilatoraction of pentoxify-Lline on microcirculation of rat crimaster muscle. Angiology,1992, 43:462.
[12].曾祥义,张书模,张荷.非胰岛素依赖型糖尿病患者循环内皮细胞的变化及临床意义[J].临床内科杂志,1996,13(5)：34.
[13].朱慧琴.112例糖尿病患者血液流变学结果分析[J].中华检验医学杂志, 2002,25(3)：180.
[14].何作云,冯兵,尹翠娥,等.红细胞聚集调控血压机理实验研究[J].中华心血管病杂志,1997,25(2)：115.
[15].张润香,胡春松,陈五一.Ⅱ型糖尿病患者红细胞和血小板聚集变化及络泰对其的影响[J].江西医学院学报,2005,45(2)：64-65.
[16]. Winocour PD. Platelet abnormalities in diabetes Mellitus[J]. Diabetes,1992,42:445.
[17].严孙杰,卓孝福,胡雯,等.糖尿病患者红细胞Na+-K+ATPase, Ca2+-ATPase活性变化[J].福建医学院学报,1996,30：257.
[18].严孙杰,卓孝福,吴长珠,等.糖尿病患者自由基与红细胞膜Na+-K+-ATPase、 Ca2+-ATPase损伤的关系[J].中华内分泌代谢杂志.1997,12：124.
[19].兰帆,张素华,邱鸿鑫,等.Ⅱ型糖尿病患者钠-钾逆转换活性改变[J].中华糖尿病杂志,2008,8：133-134.
[20].李延延,程时,潘子昂,等.Ⅱ型糖尿病患者和糖尿病鼠的红细胞形态观察[J].中华医学杂志,1992,(2)：103.
[21].严孙杰,卓孝福,潘时中,等.糖尿病患者血细胞体积增大在微血管病变中的作用[J].中国糖尿病杂志,2000,8(2)：89-91.
[22].阮长耿.血小板的形态学[M].上海：上海科学技术出版社,1987：232-235.
[23].从玉隆,王淑娟.今日临床检验学[M].北京：中国科学技术出版社,1997,4-10.
[24].王融,吴学涛,彭慧敏,等.2型糖尿病红细胞体积分布宽度的床分析[J].血栓与止血学,2004,10(3)：131-132.
[25]. Mariella Trovati, Elena M, Serenella Burzacca, et al. Impaired insulin-induced platelet antiaggregating effect in obesity and obese NIDDM patients [J]. Diabetes,1995,44(11):1318.
[26].RogerD, Nolan, Arron Ⅳ.Pathogenesis of Platlet dysfunction in diabetes. In:Derek LR.Simeon LT and Jerrold moeds. Diabetes Mellitus[M]. Philadelphia:Lippincon-Raven Publishers,1996: 832-839.
[27]. Colwell JA.Antiplatelet drugs and prevention of macrovascular disease in diabetes mellitus[J]. Metabolism,1994,41(suppl 1): 7.
[28].毛达勇,周有利,李德奎.糖尿病并血管病变患者血小板膜糖蛋白CD62p,CD63的表达及血小板四参数的研究[J].中国循环杂志.2003,18(5)：367-368.
[29].张晓鸣,杜国有.血小板参数在2型糖尿病及其并发症中的检测分析[J].右江民族医学院学报,2004,6：827-828.
[30].金长碧.2型糖尿病病人的血小板4项参数检测的临床意义[J].临床和实验医学杂志,2006,5(2)：160-161.
[31].李英兰,滕长青.2型糖尿病患者血尿酸及血小板四项参数检测的临床意义[J].青海医药杂志,2001,31(8)：10-11.
[32].李淑翠,李淑芬.血小板参数及糖化血红蛋白测定在糖尿病微血管病变中的意义[J].中国误诊学杂志2004,4(5)：725-726.
[33].贾安奎,糖尿病视网膜病变患者血小板平均体积及血小板聚集功能的测定[J].中国误诊学杂志,2006,6(18),35-38.
[34].Carr ME. Diabetes mellitus:a hypercoagulable state[J]. Diabete Complications,2001,15(1):44.
[35]. Saga T, Aoyama T, Takekoshi T. Changes in the number and volume of platelets in male elderly persons, and effects of various factors on them[J]. Nippon Ronen Igakkai Zasshi,1995,32(4):270-276.
[36].Craig BT, Katherine AE.Size dependent platelet subpopulations relationship of platelet volume to ultrastructure enzymatic activity and function[J]. Br J Haematology,1982,50:509.
[37].薛耀明,徐爱华.胰岛素依赖型糖尿病及其并发症患者血小板超微结构的形态计量学研究[J].中华内分泌代谢杂志,1995,11：16.
[38].吴伽,蔡爱玲.糖尿病合并微血管病变患者血细胞体积改变及其临床意义[J].微循环学杂志,2004,14(3)：91.
[39].金秀国,方国安,刘波,等.2型糖尿病患者血小板参数和CD62p表达率 的变化及相关关系[J].浙江临床医学,2002,4(11)：803-804.
[40].黄东生,吕善根.血小板平均容积在某些疾病中的变化及其临床意义[J].国外医学·输血及血液血分册,1995,18(6)：331-333.
[41].黄瑞勇,糖尿病人血小板各项参数变化的临床意义(附113例分析)[J]：右江医学2001,29(1)：332.
[42].董立均,邵晓颖.中西医结合治疗糖尿病视网膜病变48例分析[J].吉林中医药,2000,20(6)：52.
[43].梁光宇.冯明清教授治疗糖尿病学术思想简介[J].河南中医,2000,20(1)：15.
[44].谢学军,王明芳.糖尿病视网膜病变的病机探讨[J].中国中医眼科杂志,1995,5(2)：86-88.
[45].陈通文.糖尿病从瘀论治的临床研究进展[J].中国中医药信息杂志,2000,7(1)：18-19.
[46].李劲亮.消渴明目方治疗早期糖尿病性视网膜病变35例[J].国医论坛,2000,15(6)：24.
[47]. Tuomilehto J, Del Prato S. Mealtime glucose regulation in typ-2 diabetes[J]. Int J Clin Pract,2001,55(6):380-383.
[48]The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive treatment of diabetes on the dvelopment and progression of long-term complications in insulin dependent diabetes mellitus [J]. New Engl J Med,1993,32(14):977-986.
[49]. UK Prospective Diabetes (UKPDS) Group. Intensive blood glucose control with conventional treatment and risk of complictions in patients with Type 2 diabetes (UKPDS 33)[J]. Lancet,1998,352: 837-853.
[50]. The Diabetes Control and Complications Trial (DCCT) Research Group. The effect of intensive diabetes treatment on the progression of retinopathy in insulin-dependent diabetes mellitu[J]. Arch Ophth-almol,1995,113:36-51.
[51].Kehner EM, Aldington SJ, Stratton IM, et al. United Kingdom prospective diabetes study. Dabetic retinopathy at diagnose of non-insulin-dependent diabetes mellitus and associated risk fators[J]. Arch Ophthalmol,1998,116(3):297-303.
[52].Neely KA, Quillen DA, Schachat AP, et al. Diabetic retinopathy [J]. Med Clin North Am,1998,82(4):847-876.
[53]Chew EY, Klein ML, Ferris FL, et al. Association of elevated serum lipid levels with retinal hard exudates in diabetic retinopathy. ETDRS Report 22 [J]. Arch Ophthalmol,1996,114:1079-1084.
[54].Adiel Barak MD, Michael Regenbogen MD, Michaella Goldstein MD and Anat Loewenstein MD.Intravitreal Triamci nolone Injection for Diff-use Diabetic Macular Edema with Foveal Cystoid Changes[J]. IMAJ, 2006; 8(2):83-87.
[55].陈瑾,徐国兴.糖尿病视网膜病变相关研究进展[J].海峡科学,2007.(3)：21-23.